| Ravi S Jandhyala, MD | |
|
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
| (888) 988-2800 | |
| Not Available |
| Full Name | Ravi S Jandhyala |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 441 N Lakeview Ave, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457409328 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A51928 (California) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
University of Oklahoma professors, Helen Zgurskaya and Valentin Rybenkov, and team are addressing the challenge and critical need for new antibiotics that can fight infections caused by the multi-drug resistant bacterium, Pseudomonas aeruginosa, considered an urgent threat by the Centers for Disease Control and Prevention.
We've all heard the saying about people who can't walk and chew gum at the same time, but it turns out that walking and talking is difficult enough, especially for people with Parkinson's disease who are at increased risk for falls with injury.
MedInformatix, a leading provider of software solutions for the healthcare industry, announced the tenth anniversary of its relationships with several prominent Midwestern ophthalmology practices at the 2009 American Academy of Ophthalmology (AAO) Conference in San Francisco. In each case, the practices showcase the benefits of MedInformatix's Practice Management (PM) and Electronic Medical Records (EMR) Solution.
Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes. Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today reported unaudited financial results for the first quarter ended March 31, 2011.
› Verified 2 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
University of Oklahoma professors, Helen Zgurskaya and Valentin Rybenkov, and team are addressing the challenge and critical need for new antibiotics that can fight infections caused by the multi-drug resistant bacterium, Pseudomonas aeruginosa, considered an urgent threat by the Centers for Disease Control and Prevention.
We've all heard the saying about people who can't walk and chew gum at the same time, but it turns out that walking and talking is difficult enough, especially for people with Parkinson's disease who are at increased risk for falls with injury.
MedInformatix, a leading provider of software solutions for the healthcare industry, announced the tenth anniversary of its relationships with several prominent Midwestern ophthalmology practices at the 2009 American Academy of Ophthalmology (AAO) Conference in San Francisco. In each case, the practices showcase the benefits of MedInformatix's Practice Management (PM) and Electronic Medical Records (EMR) Solution.
Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes. Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today reported unaudited financial results for the first quarter ended March 31, 2011.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ravi S Jandhyala, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Ravi S Jandhyala, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
University of Oklahoma professors, Helen Zgurskaya and Valentin Rybenkov, and team are addressing the challenge and critical need for new antibiotics that can fight infections caused by the multi-drug resistant bacterium, Pseudomonas aeruginosa, considered an urgent threat by the Centers for Disease Control and Prevention.
We've all heard the saying about people who can't walk and chew gum at the same time, but it turns out that walking and talking is difficult enough, especially for people with Parkinson's disease who are at increased risk for falls with injury.
MedInformatix, a leading provider of software solutions for the healthcare industry, announced the tenth anniversary of its relationships with several prominent Midwestern ophthalmology practices at the 2009 American Academy of Ophthalmology (AAO) Conference in San Francisco. In each case, the practices showcase the benefits of MedInformatix's Practice Management (PM) and Electronic Medical Records (EMR) Solution.
Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes. Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today reported unaudited financial results for the first quarter ended March 31, 2011.
› Verified 2 days ago
Richard Eugene Hughes, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1300 N. Kraemer Blvd., Anaheim, CA 92806 Phone: 714-630-6363 Fax: 714-630-1921 | |
Michael Salvaggio, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Kaiser Permanente-orange County, 411 N. Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4594 | |
Abraham Harn, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave Ste 404, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Aleem A Syed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, Suite 702, Anaheim, CA 92801 Phone: 714-533-0300 Fax: 714-533-0700 | |
Dr. Jagminder Singh Bhalla, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1781 W Romneya Dr, Ste C, Anaheim, CA 92801 Phone: 714-956-3160 Fax: 714-956-1188 | |
Dr. Ashley E. Mires, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, #207, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Hyon Chong Seo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |